Tumor cells often evade immune attacks by suppressing anoikis; they may upregulate anti-apoptotic proteins (such as Bcl-2 family proteins) to inhibit apoptosis, thereby surviving even in the absence of matrix attachment, which provides a selective advantage for tumor progression. Here, BCL2 is linked to neoplasm.